Craig Sable, MD, uses artificial intelligence to evaluate a pediatric patient for rheumatic heart disease. Image courtesy of Children's National Hospital.
Researchers think this represents a potential breakthrough for low- and middle-income countries where access to high-quality imaging evaluations is still limited.
The popular drugs, originally developed to treat diabetes, are being used more and more in the United States to help obese and overweight patients lose weight.